CLINICAL_TRIALS
trial_result
· 2017-09-08
Clinical Trial Update: GSK2251052 in Complicated Urinary Tract Infection [Phase 2]
Summary
Phase 2 trial of GSK2251052 for complicated urinary tract infection was terminated; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Infections, Urinary Tract | Phase 2 | Status: TERMINATED | Results posted: 2017-09-08